MedTrace Logo

Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment

NCT02750956 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-04-26

No results posted yet for this study

Summary

The primer aim of the study was to determine serum and gingival crevicular fluid (GCF) endocan levels in periodontal diseases pathogenesis supported with vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) levels.

Conditions

  • Periodontal Disease

Interventions

PROCEDURE

Non-surgical periodontal treatment

Non-surgical periodontal therapy is an anti-infective therapy which includes both mechanical and chemotherapeutic approaches to minimize or eliminate microbial biofilm, the primary etiology of gingivitis and periodontitis

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Principal Investigators

  • ÇİĞDEM COŞKUN TÜRER · BULENT ECEVIT UNIVERSITY FACULTY OF DENTISTRY DEPARTMENT OF PERIODONTOLOGY

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-12-31
Completion
2016-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750956 on ClinicalTrials.gov